These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16816794)

  • 1. An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
    McEvoy JP
    CNS Spectr; 2006 Jul; 11(7 Suppl 7):4-8. PubMed ID: 16816794
    [No Abstract]   [Full Text] [Related]  

  • 2. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.
    Stroup TS; McEvoy JP; Swartz MS; Byerly MJ; Glick ID; Canive JM; McGee MF; Simpson GM; Stevens MC; Lieberman JA
    Schizophr Bull; 2003; 29(1):15-31. PubMed ID: 12908658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials design lessons from the CATIE study.
    Kraemer HC; Glick ID; Klein DF
    Am J Psychiatry; 2009 Nov; 166(11):1222-8. PubMed ID: 19797435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
    Citrome L; Stroup TS
    Int J Clin Pract; 2006 Aug; 60(8):933-40. PubMed ID: 16893436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).
    Kane JM
    J Clin Psychiatry; 2006 May; 67(5):831-2. PubMed ID: 16841634
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
    Lieberman JA
    Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808
    [No Abstract]   [Full Text] [Related]  

  • 7. Are we treating schizophrenia effectively? Understanding the primary outcomes of the CATIE study.
    Glazer WM; Conley RR; Citrome L
    CNS Spectr; 2006 Sep; 11(9 Suppl 10):1-13; quiz 14. PubMed ID: 16946697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
    Berkowitz RL; Patel U; Ni Q; Parks JJ; Docherty JP
    J Clin Psychiatry; 2012 Apr; 73(4):498-503. PubMed ID: 22226332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    Schizophr Res; 2011 Dec; 133(1-3):42-6. PubMed ID: 22000938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: findings from the NIMH CATIE study.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1078-85. PubMed ID: 24726579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
    Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
    Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness trials in chronic schizophrenic patients: CATIE. What can we learn?].
    Leiderman EA
    Vertex; 2009; 20(84):129-35. PubMed ID: 19543564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
    Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
    Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Atypical antipsychotics and CATIE-AD. Is this a turning point?].
    Bustin J
    Vertex; 2009; 20(84):136-43. PubMed ID: 19543565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility.
    Koranek AM; Smith TL; Mican LM; Rascati KL
    Schizophr Res; 2012 May; 137(1-3):137-40. PubMed ID: 22364675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selection of antipsychotic drugs in a psychiatric hospital based on the results of CATIE study].
    Gutiérrez-Suela F
    Farm Hosp; 2008; 32(2):83-90. PubMed ID: 18783707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
    Pecenak J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
    Melkote R; Singh A; Vermeulen A; Remmerie B; Savitz A
    Schizophr Res; 2018 Nov; 201():324-328. PubMed ID: 29804929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial.
    Levine SZ; Rabinowitz J; Faries D; Lawson AH; Ascher-Svanum H
    Schizophr Res; 2012 May; 137(1-3):141-6. PubMed ID: 22316567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing symptom response among antipsychotic medications in CATIE.
    Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
    J Clin Psychopharmacol; 2013 Feb; 33(1):123-6. PubMed ID: 23288232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.